Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G HUMPHRIES

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
British Journal of Pharmacology|July 1, 1995
Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivoR G Humphries, W Tomlinson, J A Clegg, et al.
Nature|February 4, 1988
A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumoursC G Humphries, A Shen, W A Kuziel, et al.
British Journal of Pharmacology|July 1, 1985
The effects of dopexamine on the cardiovascular system of the dogR A Brown, J B Farmer, J C Hall, et al.
British Journal of Pharmacology|June 18, 1998
P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptorsM S Fagura, I A Dainty, G D McKay, et al.
Oncotarget|September 15, 2016
The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancerShan Wang, Rahul K Kollipara, Caroline G Humphries, et al.
British Journal of Pharmacology|July 1, 1985
Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptorsR A Brown, J Dixon, J B Farmer, et al.
Cell Metabolism|September 30, 2014
Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levelsNishi Srivastava, Rahul K Kollipara, Dinesh K Singh, et al.
The Journal of Pharmacy and Pharmacology|February 1, 1996
P2T purinoceptor antagonists. A QSAR study of some 2-substituted ATP analoguesN P Tomkinson, D P Marriott, P A Cage, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2003
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis modelKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
British Journal of Pharmacology|July 1, 1995
Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivoR G Humphries, W Tomlinson, J A Clegg, et al.
Nature|February 4, 1988
A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumoursC G Humphries, A Shen, W A Kuziel, et al.
British Journal of Pharmacology|July 1, 1985
The effects of dopexamine on the cardiovascular system of the dogR A Brown, J B Farmer, J C Hall, et al.
British Journal of Pharmacology|June 18, 1998
P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptorsM S Fagura, I A Dainty, G D McKay, et al.
Oncotarget|September 15, 2016
The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancerShan Wang, Rahul K Kollipara, Caroline G Humphries, et al.
British Journal of Pharmacology|July 1, 1985
Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptorsR A Brown, J Dixon, J B Farmer, et al.
Cell Metabolism|September 30, 2014
Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levelsNishi Srivastava, Rahul K Kollipara, Dinesh K Singh, et al.
The Journal of Pharmacy and Pharmacology|February 1, 1996
P2T purinoceptor antagonists. A QSAR study of some 2-substituted ATP analoguesN P Tomkinson, D P Marriott, P A Cage, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2003
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis modelKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Pageof 4